Alcon Inc. vs Johnson & Johnson
ALC vs JNJ — side-by-side comparison from reported financials. ALC leads 4, JNJ leads 7 of 11 comparable metrics.
Alcon Inc.
ALC · Healthcare
$64.11+1.55%Strong
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | ALC | JNJ |
|---|---|---|
| Price | $64.11 | $261.79 |
| Market cap | $31.0B | $631B |
| Revenue (TTM) | $10.4B | $97.9B |
| Revenue growth | +6.1% | +5.6% |
| Net margin | 9.4% | 21.5% |
| Free cash flow | $1.74B | $22.2B |
| Net cash (debt) | ($3.84B) | ($27.8B) |
| 1-year price return | -14.0% | +37.0% |
| P/E | 38.4 | 29.9 |
| P/E vs own history (cheap-side %) | 99% | 16% |
| Dividend yield | 0.55% | 2.00% |
| Return on equity | 3% | 26% |
| Altman Z-score | 2.56 | — |
| CV checks passed | 11 of 11 | 10 of 11 |
| Employees | 25,942 | 140,800 |
Full résumé-style profiles: ALC CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.